WallStreetZenWallStreetZen

NASDAQ: TXG
10x Genomics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

TXG past revenue growth

How has TXG's revenue growth performed historically?
Company
19.81%
Industry
11.97%
Market
16.96%
TXG's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TXG's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TXG's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

TXG earnings and revenue history

Current Revenue
$618.7M
Current Earnings
-$255.1M
Current Profit Margin
-41.2%

TXG Return on Equity

Current Company
-33.1%
Current Industry
-0.2%
Current Market
188%
TXG's Return on Equity (-33.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when TXG announces earnings.

TXG Return on Assets

Current Company
-26%
Current Industry
0.8%
TXG is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

TXG Return on Capital Employed

Current Company
-29.68%
Current Industry
2.2%
TXG has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TXG vs Health Information Service Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
TXG$618.73M-$205.11M-$255.10M+33.43%N/A
EVH$1.96B-$24.79M-$142.26M+25.65%N/A
PGNY$1.09B$69.67M$62.04M+59.52%+74.65%
GDRX$750.27M$112.93M-$8.87M+24.63%N/A
CERT$354.34M$23.84M-$55.36M+16.70%N/A
View Top Health Information Service Stocks

TXG earnings dates

Next earnings date
Apr 30, 2024

10x Genomics Earnings & Revenue FAQ

What were TXG's earnings last quarter?

On Invalid Date, 10x Genomics (NASDAQ: TXG) reported Q4 2023 earnings per share (EPS) of -$0.41, up 173.33% year over year. Total 10x Genomics earnings for the quarter were -$48.95 million. In the same quarter last year, 10x Genomics's earnings per share (EPS) was -$0.15.

If you're new to stock investing, here's how to buy 10x Genomics stock.

What was TXG's earnings growth in the past year?

As of Q2 2024, 10x Genomics's earnings has grown year over year. 10x Genomics's earnings in the past year totalled -$255.10 million.

What is TXG's earnings date?

10x Genomics's earnings date is Invalid Date. Add TXG to your watchlist to be reminded of TXG's next earnings announcement.

What was TXG's revenue last quarter?

On Invalid Date, 10x Genomics (NASDAQ: TXG) reported Q4 2023 revenue of $183.98 million up 17.76% year over year. In the same quarter last year, 10x Genomics's revenue was $156.23 million.

What was TXG's revenue growth in the past year?

As of Q2 2024, 10x Genomics's revenue has grown 19.81% year over year. This is 7.84 percentage points higher than the US Health Information Services industry revenue growth rate of 11.97%. 10x Genomics's revenue in the past year totalled $618.73 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.